Intravenous antibiotic recalled due to mold: 4 things to know

AuroMedics Pharma recalled one lot of levofloxacin in 5 percent dextrose injection due to possible mold contamination.

Advertisement

1. Levofloxacin is an intravenous antibiotic used to treat various bacterial infections.

2. AuroMedics initiated the recall after receiving a customer complaint of white particulate matter in the injection solution. The company tentatively identified the substance as mold.

3. Use of a nonsterile injection could cause serious or fatal infections in patients. However, AuroMedics has not received any reports of adverse events related to the recalled product.

4. The company is notifying its hospital customers of the recall and arranging for the return of all affected products.

More articles on supply chain:

 

Mylan reaffirms $1B share buyback plan
Dr. Reddy’s recalls 1k cancer drug vials over container defect: 4 things to know
6 must-reads for supply chain leaders

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.